We are delighted to announce that Matt Chapman has been named the recipient of the 2025 David Cornfield Melanoma Fund Recognition Award. Established in 2019, this annual award recognizes individuals who demonstrate excellence and leadership in melanoma prevention, awareness, and support.

 

For more than a decade, Matt has been a dedicated volunteer and steadfast supporter of the David Cornfield Melanoma Fund. In 2025, he further deepened his involvement as a committee member and lead fundraiser for the Fund’s inaugural Private Capital Fights Melanoma event.

 

Held on September 25 and presented by Deloitte, Private Capital Fights Melanoma brought together leaders from the private capital community to advance melanoma prevention, awareness and research. Olympic Gold Medallist Tessa Virtue inspired attendees with reflections on resilience, performing under pressure, and the power of purpose. Together, 20 companies raised over $135,000 to combat melanoma in Canada – a milestone result for the David Cornfield Melanoma Fund.

 

As a Partner at TorQuest Partners and a Canadian private equity leader, Matt’s perseverance, credibility, and enthusiasm were instrumental in turning Private Capital Fights Melanoma into a successful inaugural event with enduring impact.

 

Through his dedication, Matt exemplifies the spirit of the David Cornfield Melanoma Fund Recognition Award, and we are proud to honour his contributions in 2025.